在急性髓性白血病中使用抗体或CAR-T细胞向膜抗原向
Ugo Testa1, Germana Castelli1, Elvira Pelosi1
1Department of Oncology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Cancers
|November 9, 2024
概括
抗体和CAR-T细胞对急性髓性白血病 (AML) 治疗有希望,但患者的反应因AML异质而有所不同. 未来的研究重点是克服耐药性和提高免疫疗法疗效.
科学领域:
- 免疫治疗是一种免疫疗法.
- 血液学恶性瘤是什么
- 癌症治疗方法 癌症治疗方法
背景情况:
- 急性髓性白血病 (AML) 仍然是一个具有挑战性的血液恶性瘤.
- 目前针对耐火性/复发性AML的治疗方法存在局限性.
- 免疫疗法提供了一个有前途的替代治疗策略.
研究的目的:
- 审查抗体和仿真抗原受体 (CAR) -T细胞在AML中的治疗应用.
- 分析适合免疫治疗向的AML抗原.
- 讨论AML免疫疗法的挑战和未来方向.
主要方法:
- 对AML免疫治疗现有研究的文献综述.
- 基于抗体的治疗方法的分析,包括双特异性抗体 (BsAbs) 和CAR-T细胞.
- 检查AML中免疫疗法耐药性的机制.
主要成果:
- 在用BsAbs和CAR-T细胞治疗的AML患者中观察到有限的持续反应.
- 识别了AML异质性作为影响治疗疗效的重大挑战.
- 特定的AML亚型对免疫疗法表现出敏感性.
结论:
- 了解耐药机制对于推进AML免疫疗法至关重要.
- 未来的策略,如多重抗原向,可能会改善治疗结果.
- 尽管面临挑战,免疫疗法对特定的AML患者群体具有潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480